Hi Matz, hey if you don’t mind I have some thoughts

New Post Public Reply Private Reply Replies (1) Message Board
Tennisboy matzaball #16824
990
Hi Matz, hey if you don’t mind I have some thoughts about the mailings
That Rory talked about last night. I replayed the call today and put some
notes on my thoughts. Trying to get my head around it I respect your insight and thoughts on this. Feel free to reply in pieces or how ever works in schedule.

Here are my thoughts.

I like your thinking and glad you posted it. One thought I had last night was..

Now how would they get to $10/mo per user?
Selling a few in-app purchases might be .75 here, a couple of bucks there. How does that add up to $10?

Was thinking maybe interactive video is $5/mo upgrade?
But how to you get to $10/mo?

There will be some users that don't upgrade so let's say 1/2 do. I don't know what is a fair number. But now how do you get to $20/mo per user on average?

The picture is becoming very clear now, at least for me if you connect a few things. I am sure investors remember the .35

"So if we didn't sign another new client and BTW, the rate that we are signing new clients, right, unbelievable, and we'll share that information.

If we didn't sign another new client, just what we already have, in the hundreds of thousands of users we have in the application right now and next week I'll talk numbers.

35 cents, plus all the other cost while we are getting a margin on that. Our revenue growth, I think, is going to be very impressive as we move through the rest of this year and beyond.

Just wanted to add that info"

If that $10 target is a combination of in-app tools purchases, sampling, etc. You can get there quickly. That would be $84M revenue a year if they didn't ADD ANOTHER CUSTOMER

5600% growth, but they are adding customers. They are actually pushing forward a new eLearning app that was never on anyone's radar last year. Now that is seizing an opportunity

"With regard to the second prong – in order to extract more revenue from our existing enterprise clients we’ve implemented two important initiatives. First, we’re finalizing development of a new customer facing application – as opposed to a sales CRM application for sales reps – we call it our “Learning” app which will greatly enhance our enterprise clients’ ability to recruit – enable – and retain their business builders, as well as, and most importantly, their customers. This application is a highly complementary addition to our existing sales CRM application for the direct sales industry. This application in on-track to be released this quarter and we expect it will further strengthen our leadership position in this sector."

And this new app will drive faster adoption of the other app. Get VERB to 1M users faster. This is brilliant in my opinion. You are making money with this new app and increasing revenue with the other

Companies have to prioritize and re-prioritize when high ROI opportunities pop up. Glad there are a lot of smart thinkers at VERB including the board and advisers.

Even getting to half $5/mo sooner than later would trigger the multiple to grow

At a x10 that would be a $840M

At x20, $1.7B

Whether it's x10, x15 x20 would depend on how fast the company gets there Q over Q

If the OS is 23,263,187, just at a x10 would be $36/share

You are back at that $2.40 pre-split and a lot of people are in the green and some even way green

x20 would obviously be $72/share and you are back at ~$5 pre-split

Yes there are warrants, but there is also cash that would come in as well. A lot of other things would offset those extra shares as this is doesn't include any new customers, new products, etc. Remember the new app will increase adoption even more

What would be the multiple of a company that ends up growing 5600%? It's not going to happen in one quarter. Maybe sometime next year, I don't know, but that multiple with that kind of crazy growth rate would be high

"And they are highly motivated to collaborate with us on this. Here’s why. The data our clients have generated shows that when a sales rep shares an interactive video or other information through our app – again – I’m talking about a single share by a sales rep – like a post on social media through the app – or when a rep sends an interactive video to someone by email or text – that single share results in $1.79 in revenue to corporate – our enterprise client. Many of our enterprise clients are seeing more than 40,000 shares per month from their sales reps using our app, which is generating an additional $72K in revenue per month for our enterprise clients – solely from their reps use of our app. I’m talking about a simple social share, or a product sample share or an interactive video share."

That is almost an additional $1M a year revenue! Who wouldn't want to add another $1M and also retain more associates?

"When we demo our SaaS application for a new prospect – are now north of 90%"

Most companies might be lucky to close single digits percent of deals? I don't know, but VERB is closing 90%. I think their priorities are in the right order with that close rate

Can you imagine what VERB sales deck looks like with these kind of data points?

For the non deal roadshow coming up - they have a lot of success stories to share with great data

Sorry the long notes. But did a deep dive most of last night and probably the most I have done in a couple years. The game has changed which is good in my prospective base on changing landscape!

Thanks for your thoughts!

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading